Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne. [electronic resource]
Producer: 20190715Description: 17888 p. digitalISSN:- 2045-2322
- Adolescent
- Adult
- Biomarkers -- blood
- Child
- Child, Preschool
- Clinical Trials, Phase III as Topic
- Double-Blind Method
- Dystrophin -- genetics
- Exons -- genetics
- Female
- Humans
- Longitudinal Studies
- Male
- Matrix Metalloproteinase 9 -- blood
- Muscular Dystrophy, Duchenne -- blood
- Oligonucleotides, Antisense -- genetics
- Randomized Controlled Trials as Topic
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.